Guidelines to Prevent Malevolent Use of Biomedical Research
In February 1975, a group of leading scientists, physicians, and policymakers convened at Asilomar, California, to consider the safety of proceeding with recombinant DNA research. The excitement generated by the promise of this new technology was counterbalanced by concerns regarding dangers that mi...
Authors: | ; ; ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Cambridge Univ. Press
2006
|
In: |
Cambridge quarterly of healthcare ethics
Year: 2006, Volume: 15, Issue: 4, Pages: 432-439 |
Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |